In Vivo Techniques and Strategies for Enhanced Vascularization of Engineered Bone

Vascularization: Regenerative Medicine and Tissue Engineering

Volumn , Issue , 2014, Pages 263-282

  Nguyen, Bao Ngoc B ^a   Fisher, John P ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84939980407     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b16777-17     Document Type: Chapter

References (82)

1. Abshagen, K. et al., 2009. In vivo analysis of biocompatibility and vascularization of the synthetic bone grafting substitute nanobone. Journal of Biomedical Materials Research. Part A, 91(2), 557-566.
2. Baiguera, S., Macchiarini, P., and Ribatti, D., 2012. Chorioallantoic membrane for in vivo investigation of tissue-engineered construct biocompatibility. Journal of Biomedical Materials Research. Part B, Applied Biomaterials, 100(5), 1425-1434.
3. Bose, S., Roy, M., and Bandyopadhyay, A., 2012. Recent advances in bone tissue engineering scaffolds. Trends in Biotechnology, 30(10), 546-554.
4. Buschmann, J. et al., 2012. Tissue engineered bone grafts based on biomimetic nanocomposite PLGA/amorphous calcium phosphate scaffold and human adipose-derived stem cells. Injury, 43(10), 1689-1697.
5. Chen, F. et al., 2007. Engineering tubular bone constructs. Journal of Biomechanics, 40 Suppl 1(null), S73-S79.
6. Chen, Y., Zhou, N., and Huang, X., 2012. Cell sheet technology and its application in bone tissue engineering. Zhongguo xiu fu chong jian wai ke za zhi=Zhongguo xiufu chongjian waike zazhi=Chinese Journal of Reparative and Reconstructive Surgery, 26(9), 1122-1125.
7. Correia, C. et al., 2011. In vitro model of vascularized bone: Synergizing vascular development and osteogenesis. R. Goncalves, ed. PloS One, 6(12), e28352.
8. Dejana, E., 2004. Endothelial cell-cell junctions: Happy together. Nature Reviews. Molecular Cell Biology, 5(4), 261-270.
9. Domev, H. et al., 2012. Efficient engineering of vascularized ectopic bone from human embryonic stem cell-derived mesenchymal stem cells. Tissue Engineering. Part A, 18(21-22), 2290-2302.
10. Dong, Q. et al., 2012. Prefabrication of axial vascularized tissue engineering coral bone by an arteriovenous loop: A better model. Material Science and Engineering: C, 32(6), 1536-1541.
11. Druecke, D. et al., 2004. Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: Long-term investigations using intravital fluorescent microscopy. Journal of Biomedical Materials Research. Part A, 68(1), 10-18.
12. Evensen, L. et al., 2009. Mural cell associated VEGF is required for organotypic vessel formation. Y. Cao, ed. PloS One, 4(6), e5798.
13. Fedorovich, N.E. et al., 2010. The role of endothelial progenitor cells in prevascularized bone tissue engineering: Development of heterogeneous constructs. Tissue Engineering. Part A, 16(7), 2355-2367.
14. Fei, J. et al., 2010. Imaging and quantitative assessment of long bone vascularization in the adult rat using microcomputed tomography. Anatomical Record (Hoboken, NJ: 2007), 293(2), 215-224.
15. Geris, L. et al., 2010. Mechanical loading affects angiogenesis and osteogenesis in an in vivo bone chamber: A modeling study. Tissue Engineering. Part A, 16(11), 3353-3361.
16. Geuze, R.E. et al., 2012. A differential effect of bone morphogenetic protein-2 and vascular endothelial growth factor release timing on osteogenesis at ectopic and orthotopic sites in a large-animal model. Tissue Engineering. Part A, 18(19-20), 2052-2062.
17. Ghanaati, S. et al., 2011. Scaffold vascularization in vivo driven by primary human osteoblasts in concert with host inflammatory cells. Biomaterials, 32(32), 8150-8160.
18. Gibot, L. et al., 2010. A preexisting microvascular network benefits in vivo revascularization of a microvascularized tissue-engineered skin substitute. Tissue Engineering. Part A, 16(10), 3199-3206.
19. Goldstein, S.A., 2002. Tissue engineering: Functional assessment and clinical outcome. Annals of the New York Academy of Sciences, 961, 183-192.
20. Grellier, M. et al., 2009. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials, 30(19), 3271-3278.
21. Hegen, A. et al., 2011. Efficient in vivo vascularization of tissue-engineering scaffolds. Journal of Tissue Engineering and Regenerative Medicine, 5(4), e52-e62.
22. Hoeben, A. et al., 2004. Vascular endothelial growth factor and angiogenesis. Pharmacological Reviews, 56(4), 549-580.
23. Huang, Y.-C. et al., 2005. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 20(5), 848-857.
24. Huang, Z. et al., 2010. Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine, 51(3), 305-310.
25. Hutmacher, D.W., Sittinger, M., and Risbud, M.V., 2004. Scaffold-based tissue engineering: Rationale for computer-aided design and solid free-form fabrication systems. Trends in Biotechnology, 22(7), 354-362.
26. Ilmer, M. et al., 2009. Human osteoblast-derived factors induce early osteogenic markers in human mesenchymal stem cells. Tissue Engineering. Part A, 15(9), 2397-2409.
27. Jain, R.K. et al., 2005. Engineering vascularized tissue. Nature Biotechnology, 23(7), 821-823.
28. Jaklenec, A. et al., 2012. Progress in the tissue engineering and stem cell industry “are we there yet?". Tissue Engineering. Part B, Reviews, 18(3), 155-166.
29. Kanzaki, M. et al., 2007. Dynamic sealing of lung air leaks by the transplantation of tissue engineered cell sheets. Biomaterials, 28(29), 4294-4302.
30. Kim, B.-S. and Mooney, D.J., 1998. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends in Biotechnology, 16(5), 224-230.
31. Kirkpatrick, C.J., Fuchs, S., and Unger, R.E., 2011. Co-culture systems for vascularization-Learning from nature. Advanced Drug Delivery Reviews, 63(4-5), 291-299.
32. Kneser, U. et al., 2006. Engineering of vascularized transplantable bone tissues: Induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Engineering, 12(7), 1721-1731.
33. Koyama, S. et al., 2002. Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology, 20(6), 1449-1456.
34. De la Riva, B. et al., 2009. VEGF-controlled release within a bone defect from alginate/chitosan/PLA-H scaffolds. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V, 73(1), 50-58.
35. Lanza, R., Langer, R., and Vacanti, J.P., 2007. Principles of Tissue Engineering, 3rd ed., Burlington, MA: Elsevier Academic Press.
36. Laschke, M.W. et al., 2006. Angiogenesis in tissue engineering: Breathing life into constructed tissue substitutes. Tissue Engineering, 12(8), 2093-2104.
37. Laschke, M.W. et al., 2010. In vitro and in vivo evaluation of a novel nanosize hydroxyapatite particles/poly(ester-urethane) composite scaffold for bone tissue engineering. Acta Biomaterialia, 6(6), 2020-2027.
38. Laschke, M.W. et al., 2009. In vivo biocompatibility and vascularization of biodegradable porous polyurethane scaffolds for tissue engineering. Acta Biomaterialia, 5(6), 1991-2001.
39. Lazarous, D.F. et al., 1996. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation, 94(5), 1074-1082.
40. Lehr, H.A. et al., 1993. Dorsal skinfold chamber technique for intravital microscopy in nude mice. The American Journal of Pathology, 143(4), 1055-1062.
41. Levenberg, S. et al., 2002. Endothelial cells derived from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 99(7), 4391-4396.
42. Li, Z. and Guan, J., 2011. Hydrogels for cardiac tissue engineering. Polymers, 3, 740-761.
43. Lin, Y. et al. 2000. Origins of circulating endothelial cells and endothelial outgrowth from blood. The Journal of Clinical Investigation, 105(1), 71-77.
44. Liu, X., Holzwarth, J.M., and Ma, P.X., 2012. Functionalized synthetic biodegradable polymer scaffolds for tissue engineering. Macromolecular Bioscience, 12(7), 911-919.
45. Lovett, M. et al., 2009. Vascularization strategies for tissue engineering. Tissue Engineering. Part B, Reviews, 15(3), 353-370.
46. Ma, J. et al., 2011. Coculture of osteoblasts and endothelial cells: Optimization of culture medium and cell ratio. Tissue Engineering. Part C, Methods, 17(3), 349-357.
47. Marolt, D. et al., 2012. Engineering bone tissue from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 109(22), 8705-8709.
48. Meinel, L. et al., 2004. Bone tissue engineering using human mesenchymal stem cells: Effects of scaffold material and medium flow. Annals of Biomedical Engineering, 32(1), 112-122.
49. Moon, J.J. et al., 2010. Biomimetic hydrogels with pro-angiogenic properties. Biomaterials, 31(14), 3840-3847.
50. Nerem, R.M., 2006. Tissue engineering: The hope, the hype, and the future. Tissue Engineering, 12(5), 1143-1150.
51. Nishi, M. et al., 2013. Engineered bone tissue associated with vascularization utilizing a rotating wall vessel bioreactor. Journal of Biomedical Materials Research. Part A, 101(2), 421-427.
52. Nishida, K., 2004. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium-NEJM. New England Journal of Medicine, 351(12), 1187-1196.
53. Nör, J.E. et al., 2001. Engineering and characterization of functional human microvessels in immunodeficient mice. Laboratory Investigation, 81(4), 453-463.
54. Ohashi, K. et al., 2007. Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets. Nature Medicine, 13(7), 880-885.
55. Okano, T. et al., 1993. A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). Journal of Biomedical Materials Research, 27(10), 1243-1251.
56. Ozawa, C.R. et al., 2004. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. The Journal of Clinical Investigation, 113(4), 516-527.
57. Peng, H. et al., 2005. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 20(11), 2017-2027.
58. Phelps, E.A. et al., 2010. Bioartificial matrices for therapeutic vascularization. Proceedings of the National Academy of Sciences of the United States of America, 107(8), 3323-3328.
59. Phelps, E.A. and García, A.J., 2010. Engineering more than a cell: Vascularization strategies in tissue engineering. Current Opinion in Biotechnology, 21(5), 704-709.
60. Pirraco, R.P. et al., 2011. Development of osteogenic cell sheets for bone tissue engineering applications. Tissue Engineering. Part A, 17(11-12), 1507-1515.
61. Pittenger, M.F., 1999. Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143-147.
62. Pusztaszeri, M.P., Seelentag, W., and Bosman, F.T., 2006. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. The Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society, 54(4), 385-395.
63. Ribatti, D., 2005. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: A historical review. British Journal of Haematology, 128(3), 303-309.
64. Roche, B. et al., 2012. Structure and quantification of microvascularisation within mouse long bones: What and how should we measure? Bone, 50(1), 390-399.
65. Rouwkema, J., De Boer, J., and Van Blitterswijk, C.A., 2006. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Engineering, 12(9), 2685-2693.
66. Rouwkema, J., Rivron, N.C., and Van Blitterswijk, C.A., 2008. Vascularization in tissue engineering. Trends in Biotechnology, 26(8), 434-441.
67. Schechner, J.S. et al., 2000. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proceedings of the National Academy of Sciences of the United States of America, 97(16), 9191-9196.
68. Sefcik, L.S. et al., 2008. Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineering. Biomaterials, 29(19), 2869-2877.
69. Shimizu, T. et al., 2003. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials, 24(13), 2309-2316.
70. Shin, M., Yoshimoto, H., and Vacanti, J.P., 2004. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Engineering, 10(1-2), 33-41.
71. Sikavitsas, V.I. et al., 2003. Influence of the in vitro culture period on the in vivo performance of cell/titanium bone tissue-engineered constructs using a rat cranial critical size defect model. Journal of Biomedical Materials Research. Part A, 67(3), 944-951.
72. Sittichokechaiwut, A. et al., 2010. Short bouts of mechanical loading are as effective as dexamethasone at inducing matrix production by human bone marrow mesenchymal stem cells. European Cells and Materials, 20, 45-57.
73. Song, S.J. et al., 2007. Effects of culture conditions on osteogenic differentiation in human mesenchymal stem cells. Journal of Microbiology and Biotechnology, 17(7), 1113-1119.
74. Steffens, L. et al., 2009. In vivo engineering of a human vasculature for bone tissue engineering applications. Journal of Cellular and Molecular Medicine, 13(9B), 3380-3386.
75. Tang, Y. et al., 2008. Combination of bone tissue engineering and BMP-2 gene transfection promotes bone healing in osteoporotic rats. Cell Biology International, 32(9), 1150-1157.
76. Tsigkou, O. et al., 2010. Engineered vascularized bone grafts. Proceedings of the National Academy of Sciences of the United States of America, 107(8), 3311-3316.
77. Villars, F. et al., 2000. Effect of human endothelial cells on human bone marrow stromal cell phenotype: Role of VEGF? Journal of Cellular Biochemistry, 79(4), 672-685.
78. Weinand, C. et al., 2007. Comparison of hydrogels in the in vivo formation of tissue-engineered bone using mesenchymal stem cells and beta-tricalcium phosphate. Tissue Engineering, 13(4), 757-765.
79. Wernike, E., Montjovent, M.O., and Liu, Y., 2010. VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo. European Cells and Materials, 19, 30-40.
80. Yilgor, P., 2009. Incorporation of sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials, 30(21), 3551-3559.
81. Yu, Y. et al., 2012. Insulin-like growth factor 1 enhances the proliferation and osteogenic differentiation of human periodontal ligament stem cells via ERK and JNK MAPK pathways. Histochemistry and Cell Biology, 137(4), 513-525.
82. Zhang, Z.-Y. et al., 2010. Neo-vascularization and bone formation mediated by fetal mesenchymal stem cell tissue-engineered bone grafts in critical-size femoral defects. Biomaterials, 31(4), 608-620.